Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-29

FDA Approved: MIRABEGRON — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved the original generic application for mirabegron, enabling Zydus Pharmaceuticals (USA) Inc. to market the generic form of mirabegron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

ORIG AP for MIRABEGRON (MIRABEGRON)